Groundbreaking research reveals that it's possible to isolate the therapeutic benefits of psychedelics from their ...

‘The New Valium’, as it’s been called ... Prescription rates for Pregabalin and similar drugs are greater in poorer communities, where anxiety and chronic pain are more commonly reported.

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of ...

Drug companies recommend anti-anxiety pills. TV ads promulgate pills ... Twenty years ago, physician Russell Portenoy, a prominent New York pain specialist, spearheaded the movement that ...

New research has identified distinct neural circuits for the anti-anxiety and hallucinogenic effects of psychedelics.

A new study using mouse models indicates it may ... Although DOI is not under clinical investigation as a therapeutic drug, this study underscores the importance of understanding psychedelics' basic ...

President-elect Donald J. Trump has promised to “keep men out of women’s sports” and withhold Medicare and Medicaid funding ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.